No Matches Found
No Matches Found
No Matches Found
Sampre Nutritions Ltd
Sampre Nutritions Ltd is Rated Strong Sell
Sampre Nutritions Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Sampre Nutritions Ltd is Rated Strong Sell
Sampre Nutritions Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with the latest insights into its performance and outlook.
Sampre Nutritions Ltd is Rated Strong Sell
Sampre Nutritions Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 31 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Sampre Nutritions Ltd Falls 1.22%: Death Cross and Downgrade Signal Rising Risks
Sampre Nutritions Ltd experienced a challenging week ending 20 March 2026, with its share price declining 1.22% to close at Rs.21.84, underperforming the Sensex which fell 0.28%. The week was marked by a significant technical development—the formation of a Death Cross—alongside a downgrade to a Strong Sell rating by MarketsMOJO, reflecting mounting concerns over the stock’s medium-term outlook amid fundamental weaknesses and volatile price action.
Sampre Nutritions Ltd Downgraded to Strong Sell Amid Technical and Fundamental Concerns
Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has seen its investment rating downgraded from Sell to Strong Sell as of 19 Mar 2026. This shift reflects a complex interplay of deteriorating technical indicators, weak long-term financial fundamentals, and valuation concerns despite recent positive quarterly results and impressive stock returns over the past year.
Sampre Nutritions Ltd Forms Death Cross, Signalling Potential Bearish Trend
Sampre Nutritions Ltd, a micro-cap player in the FMCG sector, has recently formed a Death Cross as its 50-day moving average (DMA) crossed below the 200 DMA, signalling a potential shift towards a bearish trend. This technical development, coupled with deteriorating momentum indicators and a downgrade in its Mojo Grade to Strong Sell, raises concerns about the stock's near-term outlook despite its impressive long-term performance.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
When is the next results date for Sampre Nutritions Ltd?
The next results date for Sampre Nutritions Ltd is 13 February 2026.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Sampre Nutritions Ltd is Rated Sell
Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 August 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 24 December 2025, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Sampre Nutritions Faces Intense Selling Pressure Amid Consecutive Losses
Sampre Nutritions Ltd experienced a pronounced decline on 5 Dec 2025, marked by exclusive selling activity and a sharp drop of 4.97% in a single trading session. This downward momentum extends over three consecutive days, signalling distress selling and a lack of buyer interest in the FMCG sector stock.
Sampre Nutritions Faces Intense Selling Pressure Amid Consecutive Losses
Sampre Nutritions Ltd experienced a pronounced decline on 4 Dec 2025, with the stock registering a 4.99% fall and exhibiting a rare scenario of exclusive selling interest. The absence of buyers and the presence of only sell orders have intensified concerns about distress selling within this FMCG sector player, marking a continuation of recent downward momentum.
Sampre Nutrition Sees Revision in Market Evaluation Amid Mixed Financial Signals
Sampre Nutrition, a microcap player in the FMCG sector, has undergone a revision in its market evaluation reflecting a nuanced shift in its financial and technical outlook. This change comes amid a backdrop of volatile stock returns and contrasting fundamental indicators, prompting investors to reassess the company’s position within the fast-moving consumer goods landscape.
Sampre Nutritions Faces Intense Selling Pressure Amidst Consecutive Losses
Sampre Nutritions Ltd experienced a pronounced decline on 3 Dec 2025, with the stock registering a sharp fall of 5.00% in a session dominated exclusively by sellers. This stark selling pressure contrasts markedly with the broader market, as the Sensex recorded a comparatively modest dip of 0.36% on the same day, signalling distress selling and a lack of buyer interest in the FMCG stock.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
